Back to 
BlackRock, Inc.
BlackRock, Inc.
SNDX7 quarters
Position history for BlackRock, Inc.'s holdings in SYNDAX PHARMACEUTICALS INC
BlackRock, Inc. holds 9M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $197.2M as of 2026-Q2. The position was increased (+9.3% shares). SNDX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$197.2M
Current Shares
9M
Total Value Change
+$77.7M
Total Shares Change
-13,943
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.